(Q37786174)

23 August 2017

title

Cardiac hypertrophy and remodelling: pathophysiological consequences and protective effects of melatonin (English)

1 reference

23 August 2017

0 references

1 reference

3

Lorena Fuentes-Broto

1 reference

23 August 2017

1

Russel J Reiter

1 reference

23 August 2017

4

Dun-Xian Tan

1 reference

23 August 2017

2

Lucien C Manchester

1 reference

23 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20823719

8 July 2024

publication date

1 September 2010

1 reference

full work available at URL

23 August 2017

http://journals.lww.com/00004872-201009001-00002

1 reference

https://api.crossref.org/works/10.1097/01.HJH.0000388488.51083.2B

8 July 2024

published in

Journal of Hypertension

1 reference

23 August 2017

volume

28 Suppl 1

1 reference

23 August 2017

page(s)

S7-12

1 reference

Cardiomyopathies: from genetics to the prospect of treatment

23 August 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1097/01.HJH.0000388488.51083.2B

Hypertrophic cardiomyopathy

8 July 2024

2

1 reference

https://api.crossref.org/works/10.1097/01.HJH.0000388488.51083.2B

Molecular targets and regulators of cardiac hypertrophy.

8 July 2024

3

1 reference

https://api.crossref.org/works/10.1097/01.HJH.0000388488.51083.2B

Sudden death in young competitive athletes. Clinical, demographic, and pathological profiles.

8 July 2024

4

1 reference

https://api.crossref.org/works/10.1097/01.HJH.0000388488.51083.2B

Hypertension and sudden cardiac death

8 July 2024

5

1 reference

https://api.crossref.org/works/10.1097/01.HJH.0000388488.51083.2B

Hypertension, left ventricular hypertrophy, and sudden death

8 July 2024

6

1 reference

https://api.crossref.org/works/10.1097/01.HJH.0000388488.51083.2B

Melatonin: the chemical expression of darkness

8 July 2024

7

1 reference

https://api.crossref.org/works/10.1097/01.HJH.0000388488.51083.2B

Pineal Melatonin: Cell Biology of Its Synthesis and of Its Physiological Interactions*

8 July 2024

8

1 reference

https://api.crossref.org/works/10.1097/01.HJH.0000388488.51083.2B

Cardiovascular diseases: protective effects of melatonin

8 July 2024

9

1 reference

https://api.crossref.org/works/10.1097/01.HJH.0000388488.51083.2B

Melatonin as a potential antihypertensive treatment

8 July 2024

10

1 reference

https://api.crossref.org/works/10.1097/01.HJH.0000388488.51083.2B

A novel electrophysiologic effect of melatonin on ischemia/reperfusion-induced arrhythmias in isolated rat hearts.

8 July 2024

11

1 reference

https://api.crossref.org/works/10.1097/01.HJH.0000388488.51083.2B

Functional MT1 and MT2 melatonin receptors in mammals

8 July 2024

12

1 reference

https://api.crossref.org/works/10.1097/01.HJH.0000388488.51083.2B

Expression of membrane and nuclear melatonin receptors in mouse peripheral organs.

8 July 2024

13

1 reference

https://api.crossref.org/works/10.1097/01.HJH.0000388488.51083.2B

MT3/QR2 melatonin binding site does not use melatonin as a substrate or a co-substrate

8 July 2024

14

1 reference

https://api.crossref.org/works/10.1097/01.HJH.0000388488.51083.2B

Inhibition of cerebellar nitric oxide synthase and cyclic GMP production by melatonin via complex formation with calmodulin

8 July 2024

15

1 reference

https://api.crossref.org/works/10.1097/01.HJH.0000388488.51083.2B

The potential role of the transcription factor RZR/ROR as a mediator of nuclear melatonin signaling

8 July 2024

16

1 reference

https://api.crossref.org/works/10.1097/01.HJH.0000388488.51083.2B

Potential role of tryptophan derivatives in stress responses characterized by the generation of reactive oxygen and nitrogen species.

8 July 2024

18

1 reference

https://api.crossref.org/works/10.1097/01.HJH.0000388488.51083.2B

Oxidative stress of the newborn in the pre- and postnatal period and the clinical utility of melatonin

8 July 2024

19

1 reference

https://api.crossref.org/works/10.1097/01.HJH.0000388488.51083.2B

Antioxidant properties of the melatonin metabolite N1-acetyl-5-methoxykynuramine (AMK): scavenging of free radicals and prevention of protein destruction

8 July 2024

20

1 reference

https://api.crossref.org/works/10.1097/01.HJH.0000388488.51083.2B

Kynuramines, metabolites of melatonin and other indoles: the resurrection of an almost forgotten class of biogenic amines

8 July 2024

21

1 reference

https://api.crossref.org/works/10.1097/01.HJH.0000388488.51083.2B

The melatonin metabolite N-acetyl-5-methoxykynuramine is a potent singlet oxygen scavenger

8 July 2024

22

1 reference

https://api.crossref.org/works/10.1097/01.HJH.0000388488.51083.2B

The circadian melatonin rhythm and its modulation: possible impact on hypertension

8 July 2024

23

1 reference

https://api.crossref.org/works/10.1097/01.HJH.0000388488.51083.2B

Potential roles of melatonin and chronotherapy among the new trends in hypertension treatment

8 July 2024

24

1 reference

https://api.crossref.org/works/10.1097/01.HJH.0000388488.51083.2B

8 July 2024

Dippers and non-dippers

25

1 reference

https://api.crossref.org/works/10.1097/01.HJH.0000388488.51083.2B

Daily nighttime melatonin reduces blood pressure in male patients with essential hypertension.

8 July 2024

26

1 reference

https://api.crossref.org/works/10.1097/01.HJH.0000388488.51083.2B

Relation between nocturnal decline in blood pressure and mortality. The Ohasama Study.

8 July 2024

27

1 reference

https://api.crossref.org/works/10.1097/01.HJH.0000388488.51083.2B

Treatment by n-acetylcysteine and melatonin increases cardiac baroreflex and improves antioxidant reserve

8 July 2024

28

1 reference

https://api.crossref.org/works/10.1097/01.HJH.0000388488.51083.2B

The effect of N-acetylcysteine and melatonin in adult spontaneously hypertensive rats with established hypertension

8 July 2024

29

1 reference

https://api.crossref.org/works/10.1097/01.HJH.0000388488.51083.2B

Effect of melatonin, captopril, spironolactone and simvastatin on blood pressure and left ventricular remodelling in spontaneously hypertensive rats.

8 July 2024

30

1 reference

https://api.crossref.org/works/10.1097/01.HJH.0000388488.51083.2B

Melatonin prevents fibrosis but not hypertrophy development in the left ventricle of NG-nitro-L-arginine-methyl ester hypertensive rats

8 July 2024

31

1 reference

https://api.crossref.org/works/10.1097/01.HJH.0000388488.51083.2B

Melatonin improves cardiovascular function and ameliorates renal, cardiac and cerebral damage in rats with renovascular hypertension.

8 July 2024

32

1 reference

https://api.crossref.org/works/10.1097/01.HJH.0000388488.51083.2B

Melatonin protects against oxidative damage and restores expression of GLUT4 gene in the hyperthyroid rat heart

8 July 2024

33

1 reference

https://api.crossref.org/works/10.1097/01.HJH.0000388488.51083.2B

Reducing oxidative/nitrosative stress: a newly-discovered genre for melatonin

8 July 2024

34

1 reference

https://api.crossref.org/works/10.1097/01.HJH.0000388488.51083.2B

Melatonin ameliorates calcium homeostasis in myocardial and ischemia-reperfusion injury in chronically hypoxic rats

8 July 2024

35

1 reference

https://api.crossref.org/works/10.1097/01.HJH.0000388488.51083.2B

Melatonin administration does not affect isoproterenol-induced LVH

8 July 2024

36

1 reference

https://api.crossref.org/works/10.1097/01.HJH.0000388488.51083.2B

Melatonin protects against isoproterenol-induced myocardial injury in the rat: antioxidative mechanisms

8 July 2024

37

1 reference

https://api.crossref.org/works/10.1097/01.HJH.0000388488.51083.2B

Melatonin reduces cardiac inflammatory injury induced by acute exercise

8 July 2024

38

1 reference

https://api.crossref.org/works/10.1097/01.HJH.0000388488.51083.2B

Melatonin reduces ventricular arrhythmias and preserves capillary perfusion during ischemia-reperfusion events in cardiomyopathic hamsters

8 July 2024

39

1 reference

https://api.crossref.org/works/10.1097/01.HJH.0000388488.51083.2B

Melatonin interactions with blood pressure and vascular function during L-NAME-induced hypertension

8 July 2024

40

1 reference

https://api.crossref.org/works/10.1097/01.HJH.0000388488.51083.2B

Melatonin: a novel protective agent against oxidative injury of the ischemic/reperfused heart

8 July 2024

42

1 reference

https://api.crossref.org/works/10.1097/01.HJH.0000388488.51083.2B

Prevention of ischemia/reperfusion-induced cardiac apoptosis and injury by melatonin is independent of glutathione peroxdiase 1.

8 July 2024

43

1 reference

https://api.crossref.org/works/10.1097/01.HJH.0000388488.51083.2B

Light/dark patterns of soluble vascular cell adhesion molecule-1 in relation to melatonin in patients with ST-segment elevation myocardial infarction

8 July 2024

44

1 reference

https://api.crossref.org/works/10.1097/01.HJH.0000388488.51083.2B

Clinical aspects of melatonin in the acute coronary syndrome

8 July 2024

45

1 reference

https://api.crossref.org/works/10.1097/01.HJH.0000388488.51083.2B

Melatonin delivery in solid lipid nanoparticles: prevention of cyclosporine A induced cardiac damage

8 July 2024

47

1 reference

https://api.crossref.org/works/10.1097/01.HJH.0000388488.51083.2B

Melatonin: an established antioxidant worthy of use in clinical trials.

8 July 2024

48

1 reference

https://api.crossref.org/works/10.1097/01.HJH.0000388488.51083.2B

The changing biological roles of melatonin during evolution: from an antioxidant to signals of darkness, sexual selection and fitness

8 July 2024

49

1 reference

https://api.crossref.org/works/10.1097/01.HJH.0000388488.51083.2B

Pineal melatonin rhythm: reduction in aging Syrian hamsters

8 July 2024

50

1 reference

https://api.crossref.org/works/10.1097/01.HJH.0000388488.51083.2B

Age-associated reduction in nocturnal pineal melatonin levels in female rats

8 July 2024

51

1 reference

https://api.crossref.org/works/10.1097/01.HJH.0000388488.51083.2B

Human melatonin production decreases with age.

8 July 2024

52

1 reference

https://api.crossref.org/works/10.1097/01.HJH.0000388488.51083.2B

8 July 2024

Identifiers

1 reference

23 August 2017

1 reference